p66Shc Deficiency in Chronic Lymphocytic Leukemia Promotes Chemokine Receptor Expression Through the ROS-Dependent Inhibition of NF-κB
Vanessa Tatangelo(University of Siena), Laura Patrussi(University of Siena)
Cited by 7
Related Papers
Negative regulation of chemokine receptor signaling and B-cell chemotaxis by p66Shc
|Cell Death and Disease|2014|22
A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients
|Biomedicine & Pharmacotherapy|2024|9
p66Shc deficiency in CLL cells enhances PD-L1 expression and suppresses immune synapse formation
|Frontiers in Cell and Developmental Biology|2024|6